illumicell AI has raised $2M in pre-seed funding to transform semen diagnostics with AI. The funding was led by investors such as KOFA Healthcare and Harvard Phoenix Venture Fund, aiming to enhance male fertility care through innovative technology.
illumicell AI has raised $2M in pre-seed funding to transform semen diagnostics with AI. The funding was led by investors such as KOFA Healthcare and Harvard Phoenix Venture Fund, aiming to enhance male fertility care through innovative technology.
04/10/25, 2:03 PM
Location
bostonMoney raised
$2 million
Industry
health diagnostics
artificial intelligence
biotechnology
health care
Round Type
pre-seed
Investors
Med Tech Syndicates, Harvard Phoenix Venture Fund, Kofa Healthcare
Techmed startup illumicell AI has secured $2M in pre-seed funding to develop its portable 'lab scanner' and AI platform focused on fluid-based diagnostics. This technology aims to provide rapid analysis of cells and biomarkers, particularly in male fertility care. With a vision to enhance the quality of healthcare, illumicell AI seeks to address critical needs in fertility assessments. The funding round included contributions from healthcare operators, clinicians, and various early-stage funds.
Company Info
Location
boston, massachusetts, united states
Additional Info
illumicell AI is a techmed startup that aims to transform fluid-based diagnostics through its portable lab scanner and real-time AI platform. Founded by a team that includes Harvard-trained physician Michel Bielecki, the company focuses on male fertility diagnostics and aims to make lab-grade testing accessible in any doctor's office. Their technology offers faster results at a reduced cost and aims to address critical needs in male fertility care. The company is also working on expanding their platform's applications to other healthcare fields.